{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:34:05Z","timestamp":1788449645263,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"DOI":"10.1007\/s10555-026-10334-1","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:41:26Z","timestamp":1778002886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The immunobiology of pancreatic cancer metastasis: premetastatic niche formation, organ-specific immune landscapes, and therapeutic opportunities"],"prefix":"10.1007","volume":"45","author":[{"given":"Daniel R.","family":"Principe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"10334_CR1","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014). Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Research, 74, 2913\u20132921.","journal-title":"Cancer Research"},{"key":"10334_CR2","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel, R. L., Kratzer, T. B., Wagle, N. S., Sung, H., & Jemal, A. (2026). Cancer statistics, 2026. CA: A Cancer Journal for Clinicians, 76, Article e70043.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10334_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2021.01.031","volume":"504","author":"DR Principe","year":"2021","unstructured":"Principe, D. R., Korc, M., Kamath, S. D., Munshi, H. G., & Rana, A. (2021). Trials and tribulations of pancreatic cancer immunotherapy. Cancer Letters, 504, 1\u201314.","journal-title":"Cancer Letters"},{"key":"10334_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218417","volume":"646","author":"KA Burton","year":"2026","unstructured":"Burton, K. A., Metropulos, A. E., Kamath, S. D., Munshi, H. G., & Principe, D. R. (2026). Bispecific T-cell engager therapy for gastrointestinal cancers. Cancer Letters, 646, Article 218417.","journal-title":"Cancer Letters"},{"key":"10334_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41416-019-0479-5","volume":"121","author":"E Karamitopoulou","year":"2019","unstructured":"Karamitopoulou, E. (2019). Tumour microenvironment of pancreatic cancer: Immune landscape is dictated by molecular and histopathological features. British Journal of Cancer, 121, 5\u201314.","journal-title":"British Journal of Cancer"},{"key":"10334_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1158\/0008-5472.CAN-25-4465","volume":"86","author":"G Mucciolo","year":"2026","unstructured":"Mucciolo, G., & Biffi, G. (2026). Lung metastases in pancreatic cancer: Timing their first breath. Cancer Research, 86, 7\u20139.","journal-title":"Cancer Research"},{"key":"10334_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1158\/0008-5472.CAN-25-3472","volume":"86","author":"EL Lasse Opsahl","year":"2026","unstructured":"Lasse Opsahl, E. L., Espinoza, C. E., Olivei, A. C., Okoye, J. O., Watkoske, H., Hoffman, M. T., et al. (2026). Fibroblast STAT3 activation drives organ-specific premetastatic niche formation. Cancer Research, 86, 22\u201339.","journal-title":"Cancer Research"},{"key":"10334_CR8","doi-asserted-by":"publisher","first-page":"6480","DOI":"10.1158\/0008-5472.CAN-17-0994","volume":"77","author":"CF Ruivo","year":"2017","unstructured":"Ruivo, C. F., Adem, B., Silva, M., & Melo, S. A. (2017). The biology of cancer exosomes: Insights and new perspectives. Cancer Research, 77, 6480\u20136488.","journal-title":"Cancer Research"},{"key":"10334_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/ncb3169","volume":"17","author":"B Costa-Silva","year":"2015","unstructured":"Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., et al. (2015). Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nature Cell Biology, 17, 816\u2013826.","journal-title":"Nature Cell Biology"},{"key":"10334_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino, A., Costa-Silva, B., Shen, T. L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., et al. (2015). Tumour exosome integrins determine organotropic metastasis. Nature, 527, 329\u2013335.","journal-title":"Nature"},{"key":"10334_CR11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/gutjnl-2020-323014","volume":"71","author":"Z Xie","year":"2022","unstructured":"Xie, Z., Gao, Y., Ho, C., Li, L., Jin, C., Wang, X., et al. (2022). Exosome-delivered CD44v6\/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment. Gut, 71, 568\u2013579.","journal-title":"Gut"},{"key":"10334_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cellimm.2014.09.004","volume":"292","author":"M Zhou","year":"2014","unstructured":"Zhou, M., Chen, J., Zhou, L., Chen, W., Ding, G., & Cao, L. (2014). Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203. Cellular Immunology, 292, 65\u201369.","journal-title":"Cellular Immunology"},{"key":"10334_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70126","volume":"39","author":"W Yang","year":"2025","unstructured":"Yang, W., Zheng, Y., Zhou, H., Liang, R., & Hu, C. (2025). Cancer-associated fibroblast-secreted exosomes regulate macrophage polarization in pancreatic cancer via the NOD1 pathway. Journal of Biochemical and Molecular Toxicology, 39, Article e70126.","journal-title":"Journal of Biochemical and Molecular Toxicology"},{"key":"10334_CR14","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.1158\/0008-5472.CAN-17-3841","volume":"78","author":"X Wang","year":"2018","unstructured":"Wang, X., Luo, G., Zhang, K., Cao, J., Huang, C., Jiang, T., et al. (2018). Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN\/PI3Kgamma to promote pancreatic cancer metastasis. Cancer Research, 78, 4586\u20134598.","journal-title":"Cancer Research"},{"key":"10334_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107990","volume":"100","author":"S Wang","year":"2021","unstructured":"Wang, S., & Gao, Y. (2021). Pancreatic cancer cell-derived microRNA-155-5p-containing extracellular vesicles promote immune evasion by triggering EHF-dependent activation of Akt\/NF-kappaB signaling pathway. International Immunopharmacology, 100, Article 107990.","journal-title":"International Immunopharmacology"},{"key":"10334_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02559-3","volume":"11","author":"B Singh","year":"2026","unstructured":"Singh, B., Gaur, P., Bose, P., Zhang, Y., Li, Y., Zhang, Z., et al. (2026). Extracellular vesicle-derived miRNA-182-5p educates macrophages towards an immunosuppressive phenotype in pancreatic cancer. Signal Transduction and Targeted Therapy, 11, Article 31.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10334_CR17","doi-asserted-by":"publisher","first-page":"8442","DOI":"10.1096\/fj.201902186R","volume":"34","author":"T Shen","year":"2020","unstructured":"Shen, T., Huang, Z., Shi, C., Pu, X., Xu, X., Wu, Z., et al. (2020). Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK-mediated endoplasmic reticulum stress. FASEB Journal, 34, 8442\u20138458.","journal-title":"FASEB Journal"},{"key":"10334_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2026.218290","volume":"643","author":"LD Meng","year":"2026","unstructured":"Meng, L. D., Jiang, L. Y., Liang, Y. Y., Zheng, Z. Z., Chen, Q., Li, D. R., et al. (2026). Tumor cell derived CCL20 exacerbates the immunosuppressive microenvironment by recruiting CCR6(+) Tregs in pancreatic cancer. Cancer Letters, 643, Article 218290.","journal-title":"Cancer Letters"},{"key":"10334_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07720-y","volume":"16","author":"T Ma","year":"2025","unstructured":"Ma, T., Guo, W. W., Zhang, M., He, W., Dongzhi, C., Gongye, X., et al. (2025). Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma. Cell Death & Disease, 16, Article 382.","journal-title":"Cell Death & Disease"},{"key":"10334_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206759","volume":"13","author":"SS Linton","year":"2018","unstructured":"Linton, S. S., Abraham, T., Liao, J., Clawson, G. A., Butler, P. J., Fox, T., et al. (2018). Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages. PLoS ONE, 13, Article e0206759.","journal-title":"PLoS ONE"},{"key":"10334_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215751","volume":"548","author":"Z He","year":"2022","unstructured":"He, Z., Wang, J., Zhu, C., Xu, J., Chen, P., Jiang, X., et al. (2022). Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis. Cancer Letters, 548, Article 215751.","journal-title":"Cancer Letters"},{"key":"10334_CR22","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.ccell.2016.04.014","volume":"29","author":"CW Steele","year":"2016","unstructured":"Steele, C. W., Karim, S. A., Leach, J. D. G., Bailey, P., Upstill-Goddard, R., Rishi, L., et al. (2016). CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma. Cancer Cell, 29, 832\u2013845.","journal-title":"Cancer Cell"},{"key":"10334_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/gutjnl-2020-322744","volume":"71","author":"X Sun","year":"2022","unstructured":"Sun, X., He, X., Zhang, Y., Hosaka, K., Andersson, P., Wu, J., et al. (2022). Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism. Gut, 71, 129\u2013147.","journal-title":"Gut"},{"key":"10334_CR24","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","volume":"19","author":"DE Sanford","year":"2013","unstructured":"Sanford, D. E., Belt, B. A., Panni, R. Z., Mayer, A., Deshpande, A. D., Carpenter, D., et al. (2013). Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: A role for targeting the CCL2\/CCR2 axis. Clinical Cancer Research, 19, 3404\u20133415.","journal-title":"Clinical Cancer Research"},{"key":"10334_CR25","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S1470-2045(16)00078-4","volume":"17","author":"TM Nywening","year":"2016","unstructured":"Nywening, T. M., Wang-Gillam, A., Sanford, D. E., Belt, B. A., Panni, R. Z., Cusworth, B. M., et al. (2016). Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: A single-centre, open-label, dose-finding, non-randomised, phase 1b trial. Lancet Oncology, 17, 651\u2013662.","journal-title":"Lancet Oncology"},{"key":"10334_CR26","doi-asserted-by":"crossref","unstructured":"Xie, F., Ren, Y. Z., Jian, Z. W., Peng, J. Y., Jiang, H. F., Lu, Y. M., et al. (2026). BCAT1-elicited branched-chain amino acid catabolism fosters neutrophil-mediated pan-metastasis in pancreatic ductal adenocarcinoma. Molecular Therapy.","DOI":"10.1016\/j.ymthe.2026.01.039"},{"key":"10334_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265725","volume":"17","author":"JP Arnoletti","year":"2022","unstructured":"Arnoletti, J. P., Reza, J., Rosales, A., Monreal, A., Fanaian, N., Whisner, S., et al. (2022). Pancreatic ductal adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation. PLoS ONE, 17, Article e0265725.","journal-title":"PLoS ONE"},{"key":"10334_CR28","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1053\/j.gastro.2018.12.044","volume":"156","author":"MC Whittle","year":"2019","unstructured":"Whittle, M. C., & Hingorani, S. R. (2019). Fibroblasts in pancreatic ductal adenocarcinoma: Biological mechanisms and therapeutic targets. Gastroenterology, 156, 2085\u20132096.","journal-title":"Gastroenterology"},{"key":"10334_CR29","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41590-025-02134-6","volume":"26","author":"M Shakiba","year":"2025","unstructured":"Shakiba, M., & Tuveson, D. A. (2025). Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer. Nature Immunology, 26, 678\u2013691.","journal-title":"Nature Immunology"},{"key":"10334_CR30","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1111\/cas.15890","volume":"114","author":"H Sato","year":"2023","unstructured":"Sato, H., Hara, T., Meng, S., Tsuji, Y., Arao, Y., Saito, Y., et al. (2023). Multifaced roles of desmoplastic reaction and fibrosis in pancreatic cancer progression: Current understanding and future directions. Cancer Science, 114, 3487\u20133495.","journal-title":"Cancer Science"},{"key":"10334_CR31","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1158\/0008-5472.CAN-15-1293","volume":"76","author":"DR Principe","year":"2016","unstructured":"Principe, D. R., DeCant, B., Mascarinas, E., Wayne, E. A., Diaz, A. M., Akagi, N., et al. (2016). TGFbeta signaling in the pancreatic tumor microenvironment promotes fibrosis and immune evasion to facilitate tumorigenesis. Cancer Research, 76, 2525\u20132539.","journal-title":"Cancer Research"},{"key":"10334_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1160824","volume":"13","author":"S Beckinger","year":"2023","unstructured":"Beckinger, S., Daunke, T., Aldag, L., Kruger, S., Heckl, S., Wesch, D., et al. (2023). Hepatic myofibroblasts exert immunosuppressive effects independent of the immune checkpoint regulator PD-L1 in liver metastasis of pancreatic ductal adenocarcinoma. Frontiers in Oncology, 13, Article 1160824.","journal-title":"Frontiers in Oncology"},{"key":"10334_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1368603","volume":"7","author":"L Lenk","year":"2017","unstructured":"Lenk, L., Pein, M., Will, O., Gomez, B., Viol, F., Hauser, C., et al. (2017). The hepatic microenvironment essentially determines tumor cell dormancy and metastatic outgrowth of pancreatic ductal adenocarcinoma. Oncoimmunology, 7, Article e1368603.","journal-title":"Oncoimmunology"},{"key":"10334_CR34","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/ncb3340","volume":"18","author":"SR Nielsen","year":"2016","unstructured":"Nielsen, S. R., Quaranta, V., Linford, A., Emeagi, P., Rainer, C., Santos, A., et al. (2016). Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis. Nature Cell Biology, 18, 549\u2013560.","journal-title":"Nature Cell Biology"},{"key":"10334_CR35","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1158\/0008-5472.CAN-17-3876","volume":"78","author":"V Quaranta","year":"2018","unstructured":"Quaranta, V., Rainer, C., Nielsen, S. R., Raymant, M. L., Ahmed, M. S., Engle, D. D., et al. (2018). Macrophage-derived granulin drives resistance to immune checkpoint inhibition in metastatic pancreatic cancer. Cancer Research, 78, 4253\u20134269.","journal-title":"Cancer Research"},{"key":"10334_CR36","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1158\/0008-5472.CAN-25-1697","volume":"86","author":"E Greene","year":"2026","unstructured":"Greene, E., Horvat, N. K., Doxie, D. B., Parihar, V. C., Kim, J., Herting, C. J., et al. (2026). High-dimensional protein analysis uncovers distinct immunologic and stromal features in primary and metastatic pancreatic ductal adenocarcinoma. Cancer Research, 86, 1753\u20131768.","journal-title":"Cancer Research"},{"key":"10334_CR37","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1158\/0008-5472.CAN-19-2080","volume":"80","author":"S Das","year":"2020","unstructured":"Das, S., Shapiro, B., Vucic, E. A., Vogt, S., & Bar-Sagi, D. (2020). Tumor cell-derived IL1beta promotes desmoplasia and immune suppression in pancreatic cancer. Cancer Research, 80, 1088\u20131101.","journal-title":"Cancer Research"},{"key":"10334_CR38","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nature04186","volume":"438","author":"RN Kaplan","year":"2005","unstructured":"Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438, 820\u2013827.","journal-title":"Nature"},{"key":"10334_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ccr.2008.11.012","volume":"15","author":"JT Erler","year":"2009","unstructured":"Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., et al. (2009). Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell, 15, 35\u201344.","journal-title":"Cancer Cell"},{"key":"10334_CR40","doi-asserted-by":"crossref","unstructured":"Albrengues, J., Shields, M. A., Ng, D., Park, C. G., Ambrico, A., Poindexter, M. E., et al. (2018). Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science, 361(6409), eaao4227.","DOI":"10.1126\/science.aao4227"},{"key":"10334_CR41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41586-025-08927-x","volume":"642","author":"G Pei","year":"2025","unstructured":"Pei, G., Min, J., Rajapakshe, K. I., Branchi, V., Liu, Y., Selvanesan, B. C., et al. (2025). Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer. Nature, 642, 212\u2013221.","journal-title":"Nature"},{"key":"10334_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI191943","author":"R Maddipati","year":"2025","unstructured":"Maddipati, R. (2025). Metastatic heterogeneity in pancreatic cancer: Mechanisms and opportunities for targeted intervention. The Journal of Clinical Investigation. https:\/\/doi.org\/10.1172\/JCI191943","journal-title":"The Journal of Clinical Investigation"},{"key":"10334_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02265-0","volume":"10","author":"X Liu","year":"2025","unstructured":"Liu, X., Song, J., Yuan, M., Zuo, F., Li, H., Tang, L., et al. (2025). Single-cell transcriptional dissection illuminates an evolution of immunosuppressive microenvironment during pancreatic ductal adenocarcinoma metastasis. Signal Transduction and Targeted Therapy, 10, Article 182.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10334_CR44","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1038\/s41467-023-40727-7","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang, S., Fang, W., Zhou, S., Zhu, D., Chen, R., Gao, X., et al. (2023). Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis. Nature Communications, 14, 5123.","journal-title":"Nature Communications"},{"key":"10334_CR45","doi-asserted-by":"publisher","first-page":"5337","DOI":"10.7150\/thno.108925","volume":"15","author":"H Liu","year":"2025","unstructured":"Liu, H., Chen, M., Hong, B., Xiao, Y., Chen, Q., & Qian, Y. (2025). Single-nucleus RNA sequencing and spatial transcriptomics reveal an immunosuppressive tumor microenvironment related to metastatic dissemination during pancreatic cancer liver metastasis. Theranostics, 15, 5337\u20135357.","journal-title":"Theranostics"},{"key":"10334_CR46","doi-asserted-by":"crossref","unstructured":"Diskin, B., Adam, S., Soto, G. S., Liria, M., Aykut, B., Sundberg, B., et al.\u00a0(2022). BTLA(+)CD200(+) B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer. Oncogene, 41, 4349\u201360.","DOI":"10.1038\/s41388-022-02425-4"},{"key":"10334_CR47","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1136\/gutjnl-2019-319912","volume":"70","author":"R Takahashi","year":"2021","unstructured":"Takahashi, R., Macchini, M., Sunagawa, M., Jiang, Z., Tanaka, T., Valenti, G., et al. (2021). Interleukin-1beta-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression. Gut, 70, 330\u2013341.","journal-title":"Gut"},{"key":"10334_CR48","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1200\/JCO.2025.43.16_suppl.4182","volume":"43","author":"CF Gaspar","year":"2025","unstructured":"Gaspar, C. F., Marret, G., Wu, B. Z., Bruce, J., Stone, S. C., Wang, B. X., et al. (2025). Integrative analysis of tumor microenvironment in advanced pancreatic cancer: Unraveling genomic and immune landscape for targeted therapies. Journal of Clinical Oncology, 43, 4182.","journal-title":"Journal of Clinical Oncology"},{"key":"10334_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02363-6","volume":"22","author":"WJ Ho","year":"2021","unstructured":"Ho, W. J., Erbe, R., Danilova, L., Phyo, Z., Bigelow, E., Stein-O\u2019Brien, G., et al. (2021). Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways. Genome Biology, 22, Article 154.","journal-title":"Genome Biology"},{"key":"10334_CR50","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1007\/s10147-022-02131-x","volume":"27","author":"T Sasaki","year":"2022","unstructured":"Sasaki, T., Nishiwada, S., Nakagawa, K., Nagai, M., Terai, T., Hokuto, D., et al. (2022). Integrative analysis identifies activated anti-tumor immune microenvironment in lung metastasis of pancreatic cancer. International Journal of Clinical Oncology, 27, 948\u2013957.","journal-title":"International Journal of Clinical Oncology"},{"key":"10334_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s43018-024-00881-3","volume":"6","author":"JM Link","year":"2025","unstructured":"Link, J. M., Eng, J. R., Pelz, C., MacPherson-Hawthorne, K., Worth, P. J., Sivagnanam, S., et al. (2025). Ongoing replication stress tolerance and clonal T cell responses distinguish liver and lung recurrence and outcomes in pancreatic cancer. Nature Cancer, 6, 123\u2013144.","journal-title":"Nature Cancer"},{"key":"10334_CR52","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1038\/s41588-025-02345-5","volume":"57","author":"M Chalabi Hajkarim","year":"2025","unstructured":"Chalabi Hajkarim, M., May, M., Amin, A. D., Jamison, J., Tagore, S., D\u2019Souza, E., et al. (2025). Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma. Nature Genetics, 57, 2728\u20132742.","journal-title":"Nature Genetics"},{"key":"10334_CR53","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","volume":"24","author":"JL Teillaud","year":"2024","unstructured":"Teillaud, J. L., Houel, A., Panouillot, M., Riffard, C., & Dieu-Nosjean, M. C. (2024). Tertiary lymphoid structures in anticancer immunity. Nature Reviews Cancer, 24, 629\u2013646.","journal-title":"Nature Reviews Cancer"},{"key":"10334_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf9419","volume":"375","author":"TN Schumacher","year":"2022","unstructured":"Schumacher, T. N., & Thommen, D. S. (2022). Tertiary lymphoid structures in cancer. Science, 375, Article eabf9419.","journal-title":"Science"},{"key":"10334_CR55","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Sautes-Fridman","year":"2019","unstructured":"Sautes-Fridman, C., Petitprez, F., Calderaro, J., & Fridman, W. H. (2019). Tertiary lymphoid structures in the era of cancer immunotherapy. Nature Reviews Cancer, 19, 307\u2013325.","journal-title":"Nature Reviews Cancer"},{"key":"10334_CR56","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","volume":"638","author":"M Amisaki","year":"2025","unstructured":"Amisaki, M., Zebboudj, A., Yano, H., Zhang, S. L., Payne, G., Chandra, A. K., et al. (2025). IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer. Nature, 638, 1076\u20131084.","journal-title":"Nature"},{"key":"10334_CR57","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","volume":"27","author":"J Yu","year":"2021","unstructured":"Yu, J., Green, M. D., Li, S., Sun, Y., Journey, S. N., Choi, J. E., et al. (2021). Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination. Nature Medicine, 27, 152\u2013164.","journal-title":"Nature Medicine"},{"key":"10334_CR58","doi-asserted-by":"crossref","unstructured":"Lee, J. C., Mehdizadeh, S., Smith, J., Young, A., Mufazalov, I. A., Mowery, C. T., et al. (2020). Regulatory T cell control of systemic immunity and immunotherapy response in liver metastasis. Science Immunology, 5(52), eaba0759.","DOI":"10.1126\/sciimmunol.aba0759"},{"key":"10334_CR59","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1158\/2326-6066.CIR-24-1074","volume":"13","author":"AN Pearson","year":"2025","unstructured":"Pearson, A. N., Waninger, J., Huber, A. K., Holcomb, E. A., James, J. G., Kyi, J., et al. (2025). Liver metastases license neutrophils through IL1 to potentiate cancer progression. Cancer Immunology Research, 13, 2023\u20132036.","journal-title":"Cancer Immunology Research"},{"key":"10334_CR60","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004638","author":"TP Brouwer","year":"2022","unstructured":"Brouwer, T. P., de Vries, N. L., Abdelaal, T., Krog, R. T., Li, Z., Ruano, D., et al. (2022). Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry. Journal for ImmunoTherapy of Cancer. https:\/\/doi.org\/10.1136\/jitc-2022-004638","journal-title":"Journal for ImmunoTherapy of Cancer"},{"key":"10334_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add1834","volume":"16","author":"A Voissiere","year":"2024","unstructured":"Voissiere, A., Gomez-Roca, C., Chabaud, S., Rodriguez, C., Nkodia, A., Berthet, J., et al. (2024). The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers. Science Translational Medicine, 16, Article eadd1834.","journal-title":"Science Translational Medicine"},{"key":"10334_CR62","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1158\/1078-0432.CCR-24-1821","volume":"31","author":"PM Grierson","year":"2025","unstructured":"Grierson, P. M., Wolf, C., Suresh, R., Wang-Gillam, A., Tan, B. R., Ratner, L., et al. (2025). Neoadjuvant BMS-813160, nivolumab, gemcitabine, and nab-paclitaxel for patients with pancreatic cancer. Clinical Cancer Research, 31, 3644\u20133651.","journal-title":"Clinical Cancer Research"},{"key":"10334_CR63","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1056\/NEJMra1610570","volume":"377","author":"EB Tapper","year":"2017","unstructured":"Tapper, E. B., & Lok, A. S. (2017). Use of liver imaging and biopsy in clinical practice. The New England Journal of Medicine, 377, 756\u2013768.","journal-title":"The New England Journal of Medicine"},{"key":"10334_CR64","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.suc.2024.05.004","volume":"104","author":"SM Ruff","year":"2024","unstructured":"Ruff, S. M., & Tsai, S. (2024). Use of diagnostic laparoscopy and peritoneal washings for pancreatic cancer. Surgical Clinics of North America, 104, 975\u2013985.","journal-title":"Surgical Clinics of North America"},{"key":"10334_CR65","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","volume":"405","author":"TF Stoop","year":"2025","unstructured":"Stoop, T. F., Javed, A. A., Oba, A., Koerkamp, B. G., Seufferlein, T., Wilmink, J. W., et al. (2025). Pancreatic cancer. Lancet, 405, 1182\u20131202.","journal-title":"Lancet"},{"key":"10334_CR66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2217\/fon.14.258","volume":"11","author":"A Galluzzo","year":"2015","unstructured":"Galluzzo, A., Genova, C., Dioguardi, S., Midiri, M., & Cajozzo, M. (2015). Current role of computed tomography-guided transthoracic needle biopsy of metastatic lung lesions. Future Oncology, 11, 43\u201346.","journal-title":"Future Oncology"},{"key":"10334_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13237330","author":"A Constantinescu","year":"2024","unstructured":"Constantinescu, A., Stoicescu, E. R., Iacob, R., Chira, C. A., Cocolea, D. M., Nicola, A. C., et al. (2024). CT-guided transthoracic core-needle biopsy of pulmonary nodules: Current practices, efficacy, and safety considerations. Journal of Clinical Medicine. https:\/\/doi.org\/10.3390\/jcm13237330","journal-title":"Journal of Clinical Medicine"},{"key":"10334_CR68","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s41568-019-0199-4","volume":"19","author":"CA Iacobuzio-Donahue","year":"2019","unstructured":"Iacobuzio-Donahue, C. A., Michael, C., Baez, P., Kappagantula, R., Hooper, J. E., & Hollman, T. J. (2019). Cancer biology as revealed by the research autopsy. Nature Reviews. Cancer, 19, 686\u2013697.","journal-title":"Nature Reviews. Cancer"},{"key":"10334_CR69","doi-asserted-by":"publisher","first-page":"548","DOI":"10.4161\/cbt.4.5.1663","volume":"4","author":"EE Embuscado","year":"2005","unstructured":"Embuscado, E. E., Laheru, D., Ricci, F., Yun, K. J., de Boom Witzel, S., Seigel, A., et al. (2005). Immortalizing the complexity of cancer metastasis: Genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy. Cancer Biology & Therapy, 4, 548\u2013554.","journal-title":"Cancer Biology & Therapy"},{"key":"10334_CR70","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/path.6271","volume":"263","author":"T Geukens","year":"2024","unstructured":"Geukens, T., Maetens, M., Hooper, J. E., Oesterreich, S., Lee, A. V., Miller, L., et al. (2024). Research autopsy programmes in oncology: Shared experience from 14 centres across the world. The Journal of Pathology, 263, 150\u2013165.","journal-title":"The Journal of Pathology"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10334-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-026-10334-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-026-10334-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T09:02:56Z","timestamp":1778058176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-026-10334-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":70,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["10334"],"URL":"https:\/\/doi.org\/10.1007\/s10555-026-10334-1","relation":{},"ISSN":["1573-7233"],"issn-type":[{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Generative AI and AI-assisted technologies were not used in the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}